-+ 0.00%
-+ 0.00%
-+ 0.00%

BioCardia CEO Peter Altman presents at H.C. Wainwright Global Investment Conference

PUBT·09/10/2026 12:31:38
Listen to the news
BioCardia CEO Peter Altman presents at H.C. Wainwright Global Investment Conference
  • BioCardia to present at the H.C. Wainwright 28th Annual Global Investment Conference on Sept. 14-16, 2026, in New York.
  • CEO Peter Altman is slated to update investors on CardiAMP regulatory timelines in Japan, US progress in the CardiAMP HF II trial.
  • Presentation also expected to cover Helix transendocardial delivery platform regulatory work, Heart3D fusion imaging platform development.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioCardia Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609100830PRIMZONEFULLFEED9823945) on September 10, 2026, and is solely responsible for the information contained therein.